MetaNovas (Yuanxing Zhiyao) has recently announced the successful closure of two consecutive financing rounds, Series A+ and Series A++, building on the momentum of its earlier Series A funding. Under conventional technological frameworks, the development of novel consumer materials typically entails a protracted timeline. However, MetaNovas has revolutionized this process by establishing a system-level operational platform anchored in Agentic AI, thereby substantially boosting the efficiency of new material development. Leveraging its 'AI-Powered Intelligent R&D Organization,' MetaNovas has achieved a remarkable feat: the bioactive ingredient with the swiftest development trajectory has completed the entire journey from conceptualization to human efficacy testing within a mere 12-month span. This accomplishment underscores the company's commitment to innovation and efficiency. MetaNovas prides itself on its meticulously structured team, which draws from a rich tapestry of founding backgrounds. The company has independently pioneered large-scale molecular language generation models and performance prediction models. Through the accumulation of high-quality data and an active learning system, MetaNovas continuously refines the accuracy of these models, ensuring they remain at the forefront of technological advancement. In addressing the comprehensive new material development process, MetaNovas has developed AI agents that have demonstrated a first-time success rate exceeding 60% for platform-recommended molecules. Several of these molecules have already yielded significant breakthroughs, further validating the company's approach. Currently, MetaNovas's pipeline development directions are expanding rapidly, with process scale-up and production efforts closely collaborating with Contract Development and Manufacturing Organizations (CDMOs). On the commercial front, MetaNovas primarily engages in joint development initiatives and material supply agreements with brand owners, fostering mutually beneficial partnerships that drive innovation and growth.